BryoSphere Biotechnologies
Burnaby, Canada
◆ About BryoSphere Biotechnologies
Vancouver-based biotech that genetically engineers moss in photobioreactors to produce plant-based bioactive ingredients for skincare.
◆ What sets it apart
They use genetically engineered moss as a low-cost, scalable biomanufacturing platform to produce rare skincare actives sustainably.
◆ Sectors
◆ Business
ModelB2B ingredients
CustomerBeauty and skincare brands that need sustainable, high-performance bioactive ingredients
◆ Notable
- Secured angel funding from OKGN WMAN Angel Funds in September 2026
- Completed a 250L pilot production campaign
- Developed BryoBright, a moss-derived ingredient enriched in aureusidin
- Filed a PCT patent application for core moss strain IP
- Raised over $1M in combined dilutive and non-dilutive capital
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does BryoSphere Biotechnologies do?
Vancouver-based biotech that genetically engineers moss in photobioreactors to produce plant-based bioactive ingredients for skincare.
Where is BryoSphere Biotechnologies based?
BryoSphere Biotechnologies is based in Burnaby, Canada, founded in 2022.
Who has invested in BryoSphere Biotechnologies?
Investors in BryoSphere Biotechnologies include OKGN WMAN Angel Funds, SOSV/IndieBio, Cape Breton Future Fund, NRC-IRAP, Mitacs and Genome BC.